NCT02070263

Brief Summary

The purpose of this prospective study is twofold: 1) to establish oral tolerance to selected tree nuts and to examine potential predictors of oral tolerance and 2) to determine the usefulness of mixed tree nut allergen food challenges in more efficiently defining tree nut allergy and oral tolerance.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2009

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2009

Completed
4.4 years until next milestone

First Submitted

Initial submission to the registry

August 8, 2013

Completed
7 months until next milestone

First Posted

Study publicly available on registry

February 25, 2014

Completed
6.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

January 10, 2019

Status Verified

January 1, 2019

Enrollment Period

11.7 years

First QC Date

August 8, 2013

Last Update Submit

January 9, 2019

Conditions

Keywords

Food allergyTree nuts

Outcome Measures

Primary Outcomes (1)

  • Oral tolerance to selected tree nuts (TN) to determine potential predictors of oral tolerance.

    This prospective, observational study uses serum IgE to specific TN, skin prick test to TN, and TN oral food challenges to establish oral tolerance.

    total -20 years

Secondary Outcomes (1)

  • Use of tree nut (TN) IgE testing to assess the risk of positive food challenges based on grouped mixed TN food challenges

    total - 20 years

Eligibility Criteria

Age3 Years - 21 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients seen at Arkansas Children's Hospital between 3-21 years of age who have tree nut food allergies.

You may qualify if:

  • Any patient between 3-21 years of age followed by the Allergy and Immunology Department at Arkansas Children's Hospital on tree nut avoidance diet.
  • Has current serum IgE test within the past 12 months to major nuts in question. All TN serum IgE are \<10
  • Children must have a stable baseline examination prior to undergoing challenge without significant symptoms of atopic dermatitis, allergic rhinoconjunctivitis, current urticaria or other allergic symptoms deemed important by the physician.
  • Children must have stable asthma and no wheezing or repetitive cough prior to challenge, nor have been treated with oral steroids for a significant asthma exacerbation within 1 month of challenge. Asthmatics that undergo lung function testing.
  • Children must have no current illness (e.g., fever or viral illness) at time of challenge.
  • The subject will be asked to restrict the use of antihistamines (short acting, 72 hours: long acting, 5-7 days), (B-agonists (12 hours), theophylline (12 hours), and cromolyn (12 hours) prior to the first mixed TN food challenge. Other medications may be continued.

You may not qualify if:

  • Any TN serum IgE ≥10.
  • Life-threatening reaction (respiratory involvement requiring medications, or shock, or gastrointestinal reaction requiring intravenous fluids) to any TN.
  • History of a reaction in the past year or severe reaction in the past 2 years or a history of a severe reaction anytime with a TN serum IgE \>5
  • Unstable asthma, gastrointestinal disease, cardiovascular disease, chronic lung disease, beta-blocker use.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Arkansas Children's Hospital

Little Rock, Arkansas, 72202, United States

Location

MeSH Terms

Conditions

Food Hypersensitivity

Condition Hierarchy (Ancestors)

Hypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Stacie M Jones, MD

    University of Arkansas for Medical Sciences / Arkansas Children's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 8, 2013

First Posted

February 25, 2014

Study Start

April 1, 2009

Primary Completion

December 1, 2020

Study Completion

December 1, 2020

Last Updated

January 10, 2019

Record last verified: 2019-01

Locations